Portfolio company
Oncompass
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Oncompass develops oncology software that identifies genetic mutations to help clinicians select personalised cancer treatment options for patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
GenomOncology
This company develops software platforms to analyse and interpret genomic data for molecular pathology labs, clinical oncologists and research institutions.
Onqo
This company develops digital health platforms and decision support software for oncology patients and medical professionals to manage cancer treatments and information.
Astron Health
This company develops a precision oncology platform that provides molecular data analysis and personalised treatment reports for cancer patients and their clinicians.
Cambridge Cancer Genomics
This company develops precision oncology software for clinicians to monitor treatment response and detect cancer relapse using genomic data and blood samples.
DNAmito
This company develops genomics-based decision support software to provide personalised radiation therapy treatment plans for cancer patients and clinicians.
Omica
This company develops artificial intelligence software to screen pathology slides for cancer biomarkers, serving hospital laboratories and biopharmaceutical partners to improve patient therapy selection.
Persona-Dx
The company develops artificial intelligence biomarker tests for tissue and blood samples to help oncologists personalise cancer diagnosis and treatment for metastatic patients.
Isabl
This company develops whole genome and transcriptome sequencing software for oncology centres and pharmaceutical companies to improve cancer diagnosis and treatment planning.
